A new OHE Research Paper has just been published on the topic of uncertainty and risk in health technology assessment (HTA) decision making. The report is concerned with uncertainty as it affects the cost effectiveness aspects of HTA.
ISPOR’s 19th Annual European Congress was held in Vienna, 29 October – 2 November 2016. Several members of the OHE team attended and contributed to the conference. This post contains a summary of their activity.
OHE’s Koonal Shah presented findings from his review of public preferences regarding end of life treatments at the Priorities 2016 conference in Birmingham. Martina Garau chaired a session on MCDA for priority setting in health care.
The Association of the British Pharmaceutical Industry, in conjunction with the Office of Health Economics, invites you to register for a webinar on Monday 18th July: New EQ-5D-5L value sets for England and the UK and implications for HTA.